
UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.

UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.

Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.

In this episode of the Drug Solutions Podcast, Jennifer Markarian, manufacturing reporter, talks about continuous manufacturing of oral solid-dosage drugs with Lawrence De Belder, executive consultant at Pharmatech Associates, a USP company.

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.

Meeting patient needs and achieving high quality are common goals for all stakeholders.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

Innovations address supply-chain constraints, serialization, and new requirements for sustainable and patient-centric designs.

ROSS Batch High Shear Mixers are a versatile tool for powder delivery and dispersion of low-viscosity liquids.

The PureVessel series provides modular storage, preparation, treatment, and mixing of liquids.

The DynaPro NanoStar II introduces advanced walk-up capabilities in DLS technology.

Rockwell Automations newest graphic terminals increase user storage, product security, and support for modern peripherals.

Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.

Huma has acquired AstraZeneca’s digital health platform, and AstraZeneca has become a shareholder of Huma in a partnership to accelerate digital-first patient care.

New report released by USP offers a look into API supply-chain vulnerabilities.

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.

Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.

USP is advancing understanding and developing guidance and standards to assist industry in implementing continuous manufacturing.

CDMO Almac Pharma Services expanded its European ultra-low temperature packaging capabilities.

Testing cleanroom garments while in use and during daily cleanroom operations is vital for contamination control.

Why critical thinking must be applied before technology to ensure regulatory compliance.

Flow Eighteeen38 is receiving a €5 million (US$5.58 million) investment from its parent company, FairJourney Biologics.

Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.